|
One-Third of Previous Vaccinators Do Not Plan to Revaccinate
|
|
Pharmacists are into the fall vaccine season but are finding that predicting vaccine uptake is proving difficult. In a new survey, about one-third of U.S. adults who previously received seasonal vaccines say they do not plan to get them this year. The same percentage explains that they do not believe they need the vaccines, even though public health officials recommend them. Read more.
|
|
|
Metformin Protective Against Long COVID, COVID Mortality
|
|
|
Most type 2 diabetes patients take metformin, which is the usual first-line prescription. In addition to lowering blood sugar, a new study published in Diabetes Care suggests those users are getting unexpected benefits—reducing the risk of death from COVID-19 infection and lowering the risk of so-called long COVID. Find out how researchers reached those conclusions.
|
|
Electronic Tool Significantly Improved Prescribing for DOACs
|
|
|
Prescribing direct oral anticoagulants (DOACs) is complex, and about 6% to 8% of dosages are incorrect. A new study suggests that an electronic patient management system can help improve prescribing and lower adverse effects. Find out how well the tool has worked with more than 120,000 U.S. military veterans treated at Veterans’ Affairs medical centers.
|
|
|
Heart Disease Risk With Aromatase Inhibitor Use in Breast Cancer
|
|
Estrogen can be protective against heart disease, and blocking it can itself increase heart disease risks. That is why the possibility that aromatase inhibitors could further increase the risk in breast cancer patients was so concerning. A new Japanese study suggests, however, that those medications do not appear to increase coronary artery calcification and are safe. Read more.
|
|
